Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Consumer Goods & Retail Personal care Medicated Skin Care in Greece
Publications

(Currently 512486 Items)


Partners


Personal care / REPORT INFORMATION

Medicated Skin Care in Greece

DateJul, 2006
Pages35
Price / format€700 / Electronic

€700 

Report Information | Custom-Tailored Research | Product Trade Lead


Abstract:
 Our Medicated Skin Care in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
- Get a detailed picture of the medicated skin care industry
- Identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop

With a network of over 600 analysts worldwide we have a unique capability to develop reliable information resources to help drive informed strategic planning..





Pharmacies dominate due to restricted distribution
Pharmacies remained the major sales channel for OTC Healthcare in Greece in 2004. The only OTC products not exclusively sold through pharmacies ere some cough and cold remedies, medicated skin care, wound treatments and vitamins and dietary supplements. Changes concerning the framework governing OTC in Greece are expected in the second half of 2005, following publication by the Minister for Health – of the newly elected conservative government – of a New Pharmaceutical Policy.





Table of contents:
 1. EXECUTIVE SUMMARY

2. OPERATING ENVIRONMENT
- 2.1 OTC Registration and Classification
- 2.2 Vitamins & Dietary Supplements Registration and Classification
- 2.3 Advertising
- 2.4 Packaging and Labelling
- 2.5 Distribution
- 2.6 De-listing or De-reimbursement
- 2.7 Traditional Remedies
- 2.8 Homeopathy
- 2.9 Generics
Table 1 Sales Evolution of Original vs Generics 1996-2002
- 2.10 Consumer Expenditure on Health Goods and Medical Services
Table 2 Consumer Expenditure on Health Goods and Medical Services 1999-2004
- 2.11 Life Expectancy
Table 3 Life Expectancy at Birth 1999-2004

3. OTC HEALTHCARE SALES
- 3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
- 3.2 Switches
- 3.3 Competitive Environment
Table 6 OTC Healthcare Company Shares 2001-2004
Table 7 OTC Healthcare Brand Shares 2001-2004
- 3.4 Leading Company Profiles – Olvos Science
Summary 1 Olvos Science Operational Indicators 2004
Summary 2 Olvos Science: Production Statistics 2004
- 3.5 Leading Company Profiles – Gerolymatos SA
Summary 3 Gerolymatos SA Operational Indicators 2004
Summary 4 Gerolymatos SA Production Statistics 2004
- 3.6 Leading Company Profiles – Lavipharm SA, Laboratoires
Summary 5 Lavipharm SA: Production Statistics 2002
- 3.7 Leading Company Profiles – Lobelin-Pharmacare SA
- 3.8 Retail Distribution
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
- 3.9 Retailer Activity and Private Label Trends
Table 10 Penetration of Private Label by Sector 2001-2004
- 3.10 Forecast Market Performance
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009

4. MEDICATED SKIN CARE SALES
- 4.1 Sector Performance
Table 13 Sales of Medicated Skin Care by Subsector: Value 1999-2004
Table 14 Sales of Medicated Skin Care by Subsector: % Value Growth 1999-2004
Table 15 Medicated Skin Care Company Shares 2001-2004
Table 16 Medicated Skin Care Brand Shares 2001-2004
Table 17 Forecast Sales of Medicated Skin Care by Subsector: Value 2004-2009
Table 18 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2004-2009
Summary 6 Medicated Skin Care: New Product Launches 2004
- 4.2 Medicated Skin Care by Herbal/Standard Split
Table 19 Herbal vs Standard Medicated Skin Care 1999/2004
- 4.3 Acne Treatments Brand Shares
Table 20 Acne Treatments Brand Shares 2001-2004
- 4.4 Hair Loss Treatments Brand Shares
Table 21 Hair Loss treatments Brand Shares 2001-2004

5. OTHER OTC

6. DEFINITIONS




Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found


Add New Buy/Sell Lead

© 2007-2010 MarketReportFinder.com